FDA Inspection 1102175 — Glaxo Operations UK Limited

Glaxo Operations UK Limited — FEI 3003262904

The FDA completed an inspection of Glaxo Operations UK Limited on Sep 6, 2019 in Ware. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 6, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ware (United Kingdom)

Citations

IDCFRDescription
145021 CFR 211.113(a)Procedures for non-sterile drug products

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.